Yahoo
OTC Markets OTCID USD

SOHM, Inc. (SHMN)

0.0007 0.0000 (0.00%)
As of November 6 at 4:00:00 PM EST. Market Open.
Chart Range Bar
Loading chart for SHMN
  • Previous Close 0.0007
  • Open 0.0007
  • Bid 0.0007 x 1347841700
  • Ask 0.0008 x 100760000
  • Day's Range 0.0007 - 0.0007
  • 52 Week Range 0.0006 - 0.0015
  • Volume 949,951
  • Avg. Volume 885,343
  • Market Cap (intraday) 2.143M
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0020
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.

www.sohm.com

145

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SHMN
17.78%
S&P 500 (^GSPC)
8.75%

1-Year Return

SHMN
47.14%
S&P 500 (^GSPC)
10.64%

3-Year Return

SHMN
35.65%
S&P 500 (^GSPC)
71.24%

5-Year Return

SHMN
80.53%
S&P 500 (^GSPC)
58.89%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -87.26%

  • Return on Assets (ttm)

    -24.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.3M

  • Net Income Avi to Common (ttm)

    -1.13M

  • Diluted EPS (ttm)

    -0.0020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.56k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -561.14k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: